Journal Mobile Options
Table of Contents
Vol. 81, No. 4, 2002
Issue release date: May 2002

Autologous Placental Blood Transfusion for the Therapy of Anaemic Neonates

Brune T. · Garritsen H. · Witteler R. · Schlake A. · Wüllenweber J. · Louwen F. · Jorch G. · Harms E.
To view the fulltext, log in and/or choose pay-per-view option

Individual Users: Register with Karger Login Information

Please create your User ID & Password





Contact Information











I have read the Karger Terms and Conditions and agree.

To view the fulltext, please log in

To view the pdf, please log in

Abstract

Almost 65% of all premature neonates with a birth weight <1,500 g receive at least one erythrocyte transfusion during their first weeks of life. In the present study, we examined the feasibility of autologous transfusions in neonates, using placental blood. Placental blood was obtained from 131 of 141 preterm and term infants using a special placental blood collecting system. Approximately 20 ml of placental blood per kilogram body weight could be harvested, irrespective of birth weight. One placental blood sample was contaminated with maternal erythrocytes; aerobe or anaerobe contamination was observed in any of the stored placental blood products (n = 119) after 35 days of storage. 19 of the 141 newborns needed allogeneic erythrocyte transfusions during the first 12 weeks of life. In 5 of these 19 patients, the amount of placental blood collected would have been enough to dispense with further allogeneic blood transfusions. After completion of the preclinical study, we transfused a total of 22 children, using autologous placental blood. 8 of the 10 infants with a birth weight between 1,000 and 2,000 g and 3 of 5 infants requiring surgical intervention directly after birth needed no further allogeneic blood transfusions. We, therefore, conclude that the collection and preparation of placental blood is feasible for clinical use. The target groups of neonates who are most likely to benefit are infants with a birth weight between 1,000 and 2,000 g and neonates requiring surgical intervention directly after birth.



Copyright / Drug Dosage

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in goverment regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

References

  1. Shannon KM: Anaemia of prematurity: Progress and prospects. Am J Pediatr Hematol Oncol 1990;12:14–20.
  2. Strauss RG: Neonatal anaemia: Pathophysiology and treatment. Immunol Invest 1995;24:341–351.

    External Resources

  3. Obladen M, Sachsenweger M, Stahnke M: Blood sampling in very low birth weight infants receiving different levels of intensive care. Eur J Pediatr 1988;147:399–404.
  4. Rhondeau SM, Christensen RD, Ross MP, Rothstein G, Simmons MA: Responsiveness to recombinant human erythropoietin of marrow erythroid progenitors from infants with the ‘anaemia of prematurity’. J Pediatr 1988;112:935–940.

    External Resources

  5. Shannon KM, Mentzer WC, Abels RI, Freeman P, Newton N, Thompson D, Sniderman S, Ballard R, Phibbs RH: Recombinant human erythropoietin in the anaemia of prematurity: Results of a placebo-controlled pilot study. J Pediatr 1991;118:949–955.
  6. Shannon KM, Naylor GS, Torkildson JC, Clemons GK, Schaffner V, Goldman SL, Lewis K, Bryant P, Phibbs R: Circulating erythroid progenitors in the anaemia of prematurity. N Engl J Med 1987;317:728–733.

    External Resources

  7. Stockman JA: Anaemia of prematurity. Semin Hematol 1975;12:163–173.
  8. Dallman PR: Anaemia of prematurity. Annu Rev Med 1981;32:143–160.
  9. Bifano EM, Curran TR: Minimizing donor blood exposure in the neonatal intensive care unit. Clin Pediatr 1995;22:657–669.
  10. Dallman PR: Anaemia of prematurity: The prospects for avoiding blood transfusions by treatment with recombinant human erythropoietin. Adv Pediatr 1993;40:385–403.
  11. Heese HD, Smith S, Watermeyer S, Dempster WS, Jakubiec L: Prevention of iron deficiency in preterm neonates during infancy. S Afr Med J 1990;77:339–345.
  12. Rabe H, Wacker A, Huelskamp G, Hoernig-Franz I, Schulze-Everding A, Harms E, Cirkel U, Louwen F, Witteler R, Schneider HP: A randomised controlled trial of delayed cord clamping in very low birth weight preterm infants. Eur J Pediatr 2000;159:775–777.
  13. Kinmond S, Aitchison TC, Holland BM, Jones JG, Turner TL, Wardrop C: Umbilical cord clamping and preterm infants: A randomized trial. BMJ 1993;306:172–175; letters BMJ 1993;306:578–579.
  14. Usher R, Stephard M, Lind J: The blood volume of the newborn infant and placental transfusion. Acta Paediatr Scand 1963;52:497–512.

    External Resources

  15. Wardrop CAJ, Holland BM: The role and vital importance of placental blood to the newborn infant. J Perinat Med 1995;23:139–143.

    External Resources

  16. Brandes JM, Timov-Tritsch I, Suchov P: Autologous heparinized placental blood transfusion for the treatment of the anemic monozygotic twin. Presented to the Haifa Obstetrical Society, Haifa, Israel, 1977.
  17. Paxon CL: Collection and use of autologous fetal blood. Am J Obstet Gynecol 1979;134:708–710.

    External Resources

  18. Brandes JM, Roth EF, Berk PD, Bottone E, Milano CT, Sarkozi L, Zaroulis CG: Collection and preservation of human placental blood. Transfusion 1983;23:325–327.

    External Resources

  19. Abel M, Elsinger W, Sutor AH, Gregorio G, Peukert W: Untersuchungen zur transfusionsmedizinischen Validität von autologem Plazentablut. Infusionstherapie 1985;12:197–200.
  20. Bifano EM, Dracker RA, Lorah K, Palit A: Collection and 28-day storage of human placental blood. Pediatr Res 1994;36:90–94.

    External Resources

  21. Horn S, Mazor D, Zmora E, Meyerstein N: Storage-induced changes in human newborn red cells. Transfusion 1987;27:411–414.
  22. Ballin A, Arbel E, Kenet G, Berar M, Kohelet D, Tanay A, Zakut H, Meytes D: Autologous umbilical cord blood transfusion. Arch Dis Child 1995;73:F181–F183.
  23. Eichler E, Schaible T, Richter E, Zieger W, Voller K, Leveringhaus A, Goldmann SF: Cord blood as a source of autologous RBCs for transfusion to preterm infants Transfusion 2000;40:1111–1117.
  24. Jamaer D: The use of the double cell population phenomena of the Gel test in posttransfusion complications and after bone marrow transplantation: Present and the future of the Gel test. Presentations and Posters from the First International Symposium, Montreux 1993. Cressier/FR, DiaMed, 1994, pp 88–91.
  25. Brown MS, Berman ER, Luckey D: Prediction of the need for transfusion during anaemia of prematurity. J Pediatr 1990;116:773–778.
  26. Brossard Y, Van Nifterik J, De Lachaux V, Huchet J, Chavinie J, Francoual C, Lemanceau G, Benbuman M, Gerota I, Traineau R, Adam M, Gluckman E, Richard P, Thierry D: Collection of placental blood with a view to hemopoietic reconstitution. Nouv Rev Fr Hématol 1990;32:427–429.
  27. Rubinstein P, Rosenfield RE, Adamson JW, Stevens CE: Stored placental blood for unrelated bone marrow reconstitution. Blood 1993;81:1679–1690.
  28. Ballin A, Kenet G, Gutman R, Samara Z, Zakut H, Meytes D: Autologous cord blood transfusion. Acta Paediatr 1994;83:700–703.

    External Resources

  29. Yao AC, Lind J: Placental Transfusion: A Clinical and Physiological Study. Springfield, Thomas, 1982.
  30. Anderson S, Fangman J, Wager G, Uden D: Retrieval of placental blood from the umbilical vein to determine volume, sterility, and presence of clot formation. Am J Dis Child 1992;146:36–39.
  31. Golden SM, O’Brian WF, Lissner C, Cefalo RC, Schumacher H, Stass S: Hematologic and bacteriologic assessment of autologous cord blood for neonatal transfusion. J Pediatr 1980;97:810–812.

    External Resources

  32. Bifano EM, Palit A, Lorah K, Dracker R: Neonatal autologous transfusion: A potential form of hemotherapy (abstract). Pediatr Res 1990/91;29:273.
  33. Linderkamp O, Nelle M, Kraus M, Zilow EP: The effect of early and late cord-clamping on blood viscosity and other hemorheological parameters in full-term neonates. Acta Paediatr 1992;81:745–750.

    External Resources

  34. Kretschmer V: Aktuelle Aspekte zur präoperativen Eigenblutspende von juristischer Tragweite. Infusionstherapie 1992;19:53–55.


Pay-per-View Options
Direct payment This item at the regular price: USD 38.00
Payment from account With a Karger Pay-per-View account (down payment USD 150) you profit from a special rate for this and other single items.
This item at the discounted price: USD 26.50